Outcome of pregnancy in type 1 diabetic patients treated with insulin lispro or regular insulin: an Italian experience
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Some studies have shown that fetal outcome observed in patients using insulin lispro is much the same as in pregnant women using regular insulin. This study aims to analyze the Italian data emerging from a multinational, multicenter, retrospective study on mothers with type 1 diabetes mellitus before pregnancy, comparing those treated with insulin lispro for at least 3 months before and 3 months after conception with those treated with regular insulin. The data collected on pregnant women with diabetes attending 15 Italian centers from 1998 to 2001 included: HbA1c at conception and during the first and third trimesters, frequency of severe hypoglycemic episodes, spontaneous abortions, mode and time of delivery, fetal malformations and mortality. Seventy-two diabetic pregnancies treated with lispro and 298 treated with regular insulin were analyzed, revealing a trend towards fewer hypoglycemic episodes in the former, who also had a significantly greater reduction in HbA1c during the first trimester. The rate of congenital malformations was similar in the offspring of the two groups of women treated with insulin lispro or regular insulin. These findings suggest that insulin lispro could be useful for the treatment of hyperglycemia in type 1 diabetic pregnant women.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Rapid-acting insulin analogs are likely more able than regular human insulin to help a woman achieve postprandial blood glucose targets and are less likely to cause hypoglycemia; fetal outcomes, however, seem comparable (28–30).”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [30]
In the citing paper
“Rapid-acting insulin analogs are likely more able than regular human insulin to help a woman achieve postprandial blood glucose targets and are less likely to cause hypoglycemia; fetal outcomes, however, seem comparable (28–30).”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [30]
In the citing paper
“Rapid-acting insulin analogs are likely more able than regular human insulin to help a woman achieve postprandial blood glucose targets and are less likely to cause hypoglycemia; fetal outcomes, however, seem comparable (28–30).”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [30]
In the citing paper
“In most other respects, rapid-acting insulin and regular insulin are comparable during pregnancy (30, 158–162).”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [30]
In the citing paper
“Rapid-acting insulin does not increase the risk of teratogenicity (30, 157, 158, 163–165).”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [30]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Gynecologists (2009) · Cited by 1,037
Diagnosis and management of preeclampsia and eclampsia
(2002) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(02)80002-9 · Cited by 703
Casson, I. F., Clarke, C. A., Howard, C. V., McKendrick, O., Pennycook, S., Pharoah, P. O. D., Platt, M. J., Stanisstreet, M., van Velszen, D., & Walkinshaw, S. (1997) · BMJ · doi:10.1136/bmj.315.7103.275 · Cited by 523
Errors of morphogenesis: Concepts and terms
Spranger, J., Benirschke, K., Hall, J. G., Lenz, W., Lowry, R. B., Opitz, J. M., Pinsky, L., Schwarzacher, H. G., & Smith, D. W. (1982) · The Journal of Pediatrics · doi:10.1016/s0022-3476(82)80261-8 · Cited by 405
Insulin analogues and their potential in the management of diabetes mellitus
Bolli, G. B., Di Marchi, R. D., Park, G. D., Pramming, S., & Koivisto, V. A. (1999) · Diabetologia · doi:10.1007/s001250051286 · Cited by 349
Anderson, J. H., Brunelle, R. L., Koivisto, V. A., Pfützner, A., Trautmann, M. E., Vignati, L., & DiMarchi, R. (1997) · Diabetes · doi:10.2337/diab.46.2.265 · Cited by 319
Suhonen, L., Hiilesmaa, V., & Teramo, K. (2000) · Diabetologia · doi:10.1007/s001250050010 · Cited by 302
Maternal triglyceride levels and newborn weight in pregnant women with normal glucose tolerance
Di Cianni, G., Miccoli, R., Volpe, L., Lencioni, C., Ghio, A., Giovannitti, M. G., Cuccuru, I., Pellegrini, G., Chatzianagnostou, K., Boldrini, A., et al. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01336.x · Cited by 257
Self-citationSt Vincent’s Declaration 10 years on: outcomes of diabetic pregnancies
Platt, M. J., Stanisstreet, M., Casson, I. F., Howard, C. V., Walkinshaw, S., Pennycook, S., & McKendrick, O. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00665.x · Cited by 141
Insulin lispro and regular insulin in pregnancy
Bhattacharyya, A. (2001) · QJM · doi:10.1093/qjmed/94.5.255 · Cited by 114
Research works printed but not linked: 6
- American Diabetes Association (2006) Preconception care of women with diabetes in pregnancy. Diabetes Care 29(Suppl 1):S28–S29
- Rosen SG, Engel SS (1998) Use of insulin lispro in pregnant women with diabetes mellitus. Diabetes 47(Suppl 1):A437
- Garg SK, Anil S, Gottlieb P (2001) Better glycaemic control and reduced need for cesarean sections with insulin lispro treated pregnancies in type 1 diabetes. Diabetes 20(Suppl 2):A383
- Alawi H (2001) Use of insulin lispro in pregnant women. Diabetes 50(Suppl 2):A381
- Cypryk K, Symczak W, Sobbczak M, Pertynska-Marczewska M, Zawodniak-Szalapska M, Wilczynsky J, Lewinski A (2003) The comparison of pregnancy complications and perinatal outcome between diabetic women treated with Humalog and human insulin. Diabetes Metab 29:4S213
- Mello G, Parretti E, Tondi F, Borri P, Scarselli G (2006). The effect of varying degrees of post-prandial glucose excursion in fetal mass growth in non-diabetic pregnancies. 5th international workshop-conference on gestational diabetes, p 108
Cited by
Hod, M., Kapur, A., Sacks, D. A., Hadar, E., Agarwal, M., Di Renzo, G. C., Roura, L. C., McIntyre, H. D., Morris, J. L., & Divakar, H. (2015) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(15)30033-3 · Cited by 767
Handelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.gl · Cited by 629
Gestational diabetes: the need for a common ground
Reece, E. A., Leguizamón, G., & Wiznitzer, A. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60515-8 · Cited by 589
Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline
Blumer, I., Hadar, E., Hadden, D. R., Jovanovič, L., Mestman, J. H., Murad, M. H., & Yogev, Y. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2465 · Cited by 561
Handelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.glsuppl · Cited by 559
Metadata
- Authors
- Lapolla, A., Dalfrà, M. G., Spezia, R., Anichini, R., Bonomo, M., Bruttomesso, D., Di Cianni, G., Franzetti, I., Galluzzo, A., Mello, G., Menato, G., Napoli, A., Noacco, G., Parretti, E., Santini, C., Scaldaferri, E., Scaldaferri, L., Songini, M., Tonutti, L., Torlone, E., Gentilella, R., Rossi, A., & Valle, D.
- Affiliations
- University of Padua (IT)
- Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda (IT)
- Aziende Socio Sanitarie Territoriale dei Sette Laghi (IT)
- University of Palermo (IT)
- University of Florence (IT)
- Ospedale Sant'Anna (IT)
- Sapienza University of Rome (IT)
- Ospedale Santa Maria della Misericordia di Udine (IT)
- Azienda-Unita' Sanitaria Locale Di Cesena (IT)
- Azienda Ospedaliera G. Brotzu (IT)
- University of Perugia (IT)
- Eli Lilly (Italy) (IT)
- Corresponding author
- Lapolla, Annunziata
- ORCID
- Venue
- Acta Diabetologica
- Published
- 2008-01-29
- Volume
- 45
- Issue
- 1
- Pages
- 61-66
- ISSN
- 0940-5429 (ISSN-L)
- 1432-5233
- OpenAlex
- W2080005958
- Cited by
- 58
- References
- 30
- Citations by year
- 2026: 1 · 2022: 2 · 2019: 5 · 2018: 2 · 2017: 1 · 2016: 2 · 2015: 12 · 2014: 1 · 2013: 6 · 2012: 7
- FWCI
- 7.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Acta Diabetologica (publishedVersion)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 1 diabetes, pregnancy, insulin lispro, regular insulin, glycemic control, HbA1c, hypoglycemia, congenital malformations, fetal outcomes, miscarriage, mode of delivery
- MeSH terms
- Birth Weight, Chromatography, High Pressure Liquid, Diabetes Mellitus, Type 1, Female, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Infant, Newborn, Infant, Small for Gestational Age, Insulin, Italy, Pregnancy, Pregnancy Complications, Retrospective Studies, Insulin Lispro
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Outcome of pregnancy in type 1 diabetic patients treated with insulin lispro or regular insulin: an Italian experience. https://app.cochat.ai/papers/10.1007/s00592-008-0024-0
- The paper
- Lapolla, A., Dalfrà, M. G., Spezia, R., Anichini, R., Bonomo, M., Bruttomesso, D., Di Cianni, G., Franzetti, I., Galluzzo, A., Mello, G., Menato, G., Napoli, A., Noacco, G., Parretti, E., Santini, C., Scaldaferri, E., Scaldaferri, L., Songini, M., Tonutti, L., . . . Valle, D. (2008). Outcome of pregnancy in type 1 diabetic patients treated with insulin lispro or regular insulin: an Italian experience. Acta Diabetologica. https://doi.org/10.1007/s00592-008-0024-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.